September 19, 2017

Morphotek to Present Preclinical Data on Antibody-Drug Conjugate MORAb-202 at the Upcoming 8th Annual World ADC in San Diego
Read More

September 6, 2017

Morphotek Announces Collaboration Agreement with the Johns Hopkins University to Research and Develop Novel Monoclonal Antibody-Based Therapies Targeting Missplicing-Associated Surface Antigens
Read More

September 5, 2017

Morphotek, Inc. Announces an Agreement with Fujirebio Diagnostics, Inc to Commercialize the CA125 II Assay as A Companion Diagnostic for Farletuzumab
Read More

News & Events > News Archive > 2017 News